Literature DB >> 21787357

Impeded protein folding and function in active inflammatory bowel disease.

J Jasper Deuring1, Maikel P Peppelenbosch, Ernst J Kuipers, C Janneke van der Woude, Colin de Haar.   

Abstract

The intestinal tract is covered by a total of 300 square metres of IECs (intestinal epithelial cells) that covers the entire intestinal mucosa. For protection against luminal xenobiotics, pathogens and commensal microbes, these IECs are equipped with membrane-bound transporters as well as the ability to secrete specific protective proteins. In patients with active IBD (inflammatory bowel disease), the expression of these proteins, e.g. ABC (ATP-binding cassette) transporters such as ABCG2 (ABC transporter G2) and defensins, is decreased, thereby limiting the protection against various luminal threats. Correct ER (endoplasmic reticulum)-dependent protein folding is essential for the localization and function of secreted and membrane-bound proteins. Inflammatory triggers, such as cytokines and nitric oxide, can impede protein folding, which causes the accumulation of unfolded proteins inside the ER. As a result, the unfolded protein response is activated which can lead to a cellular process named ER stress. The protein folding impairment affects the function and localization of several proteins, including those involved in protection against xenobiotics. In the present review, we discuss the possible inflammatory pathways affecting protein folding and eventually leading to IEC malfunction in patients with active IBD.

Entities:  

Mesh:

Year:  2011        PMID: 21787357     DOI: 10.1042/BST0391107

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  6 in total

1.  Profiling of ABC transporters during active ulcerative colitis and in vitro effect of inflammatory modulators.

Authors:  Nirmal Verma; Vineet Ahuja; Jaishree Paul
Journal:  Dig Dis Sci       Date:  2013-03-20       Impact factor: 3.199

2.  Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.

Authors:  Vibeke Andersen; Katrine Svenningsen; Lina Almind Knudsen; Axel Kornerup Hansen; Uffe Holmskov; Allan Stensballe; Ulla Vogel
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

3.  Bitter melon protects against ER stress in LS174T colonic epithelial cells.

Authors:  Dale A Kunde; Wai Chin Chong; Prathiba V Nerurkar; Kiran D K Ahuja; Jeremy Just; Jason A Smith; Nuri Guven; Rajaraman D Eri
Journal:  BMC Complement Altern Med       Date:  2017-01-03       Impact factor: 3.659

4.  Low dose Naltrexone for induction of remission in inflammatory bowel disease patients.

Authors:  Mitchell R K L Lie; Janine van der Giessen; Gwenny M Fuhler; Alison de Lima; Maikel P Peppelenbosch; Cokkie van der Ent; C Janneke van der Woude
Journal:  J Transl Med       Date:  2018-03-09       Impact factor: 5.531

5.  Profiles of microRNA networks in intestinal epithelial cells in a mouse model of colitis.

Authors:  Juneyoung Lee; Eun Jeong Park; Yoshikazu Yuki; Shandar Ahmad; Kenji Mizuguchi; Ken J Ishii; Motomu Shimaoka; Hiroshi Kiyono
Journal:  Sci Rep       Date:  2015-12-09       Impact factor: 4.379

6.  Fizzy: feature subset selection for metagenomics.

Authors:  Gregory Ditzler; J Calvin Morrison; Yemin Lan; Gail L Rosen
Journal:  BMC Bioinformatics       Date:  2015-11-04       Impact factor: 3.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.